HARDING LOEVNER LP – Vertex Pharmaceuticals Incorporated Transaction History
HARDING LOEVNER LP portfolio value:
$474.79M
portfolio value
HARDING LOEVNER LP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.41% | -93.87K shares | -13.74M | $289.54 | 1.63M |
Q2 2022 | share | Decrease | -2.01% | -35.58K shares | 71.20M | $281.79 | 1.73M |
Q1 2022 | share | Decrease | -5.98% | -112.59K shares | 4.08M | $260.97 | 1.76M |
Q4 2021 | share | Decrease | -1.53% | -29.23K shares | 66.60M | $222.45 | 1.88M |
Q3 2021 | share | Decrease | -4.40% | -87.97K shares | -56.41M | $181.39 | 1.91M |
Q2 2021 | share | Increase | +0.81% | 15.98K shares | -23.07M | $201.63 | 1.99M |
Q1 2021 | share | Decrease | -2.94% | -60.00K shares | -56.71M | $214.89 | 1.98M |
Q4 2020 | share | Increase | +2.13% | 42.55K shares | -61.52M | $236.34 | 2.04M |
Q3 2020 | share | Decrease | -1.05% | -21.22K shares | -42.55M | $272.12 | 2.00M |
Q2 2020 | share | Decrease | -1.25% | -25.50K shares | 99.79M | $290.31 | 2.02M |
Q1 2020 | share | Decrease | -2.12% | -44.38K shares | 29.18M | $237.95 | 2.04M |
Q4 2019 | share | Decrease | -9.96% | -231.42K shares | 64.39M | $218.95 | 2.09M |
Q3 2019 | share | Increase | +213.77% | 1.58M shares | 257.80M | $169.42 | 2.32M |
Q2 2019 | share | Decrease | -1.55% | -11.67K shares | -2.56M | $183.38 | 740.37K |
Q1 2019 | share | Increase | +1089818.84% | 751.97K shares | 138.32M | $183.95 | 752.04K |
Q4 2018 | share | Increase | 0.00% | 69 shares | 11K | $165.71 | 69 |